26.12

0.38% -0.10

Pre-market: 26.91 0.79 +3.02%

Phibro Animal Health Corp (PAHC)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Phibro Animal Health Corp stock is traded at $26.12, with a volume of 437.41K. It is down -0.38% in the last 24 hours and up +30.27% over the past month. Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Previous Close:

$26.22

Open:

$26.3

24h Volume:

437.41K

Relative Volume:

2.36

Market Cap:

$1.06B

Revenue:

$982.01M

Net Income/Loss:

$14.80M

P/E Ratio:

70.59

EPS:

0.37

Net Cash Flow:

$37.02M

1W Performance:

+18.62%

1M Performance:

+30.27%

6M Performance:

+48.32%

1Y Performance:

+125.76%

1-Day Range:

$25.23

$26.49

1-Week Range:

$21.94

$26.49

52-Week Range:

$11.24

$26.49

Phibro Animal Health Corp Stock (PAHC) Company Profile

Name

Phibro Animal Health Corp

Sector

Healthcare (1176)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

201-329-7300

Address

GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ

Employee

1,940

Twitter

@phibroeurope

Next Earnings Date

2024-12-06

Latest SEC Filings

PAHC's Discussions on Twitter

Compare PAHC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PAHC Phibro Animal Health Corp	26.12	1.06B	982.01M	14.80M	37.02M	0.37
ZTS Zoetis Inc	174.29	78.63B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.85	44.54B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.44	42.61B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.59	18.79B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	127.56	13.55B	612.78M	-86.37M	-62.91M	-0.87

Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-10-24	Initiated	JP Morgan	Neutral
Dec-07-23	Initiated	Exane BNP Paribas	Underperform
Dec-21-22	Initiated	ROTH Capital	Buy
Jul-25-22	Downgrade	Barclays	Equal Weight → Underweight
Jan-10-22	Upgrade	Barclays	Underweight → Equal Weight
Nov-18-21	Initiated	Morgan Stanley	Equal-Weight
Aug-05-21	Resumed	Credit Suisse	Neutral
Jul-07-21	Downgrade	Barclays	Equal Weight → Underweight
Aug-06-20	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Feb-06-20	Downgrade	Gabelli & Co	Buy → Hold
Jan-28-20	Upgrade	Barclays	Underweight → Equal Weight
Sep-05-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Aug-29-19	Reiterated	BofA/Merrill	Underperform
Jun-11-19	Initiated	Barclays	Underweight
May-23-19	Initiated	Guggenheim	Neutral
May-09-19	Upgrade	Gabelli & Co	Hold → Buy
Aug-23-17	Resumed	BofA/Merrill	Underperform
Jun-02-17	Downgrade	Credit Suisse	Outperform → Neutral
Dec-15-16	Initiated	Piper Jaffray	Overweight
Nov-11-16	Downgrade	Macquarie	Neutral → Underperform
Nov-10-16	Downgrade	Gabelli & Co	Buy → Hold
Apr-11-16	Reiterated	Guggenheim	Buy
Feb-04-16	Initiated	Credit Suisse	Outperform
Jan-15-16	Downgrade	Barclays	Overweight → Underweight
Sep-30-15	Initiated	Gabelli & Co	Buy
Apr-24-15	Reiterated	Barclays	Overweight
Apr-21-15	Downgrade	Morgan Stanley	Equal-Weight → Underweight
May-06-14	Initiated	Barclays	Overweight

View All

Phibro Animal Health Corp Stock (PAHC) Latest News

Feb 11, 2025

Phibro Animal Health (PAHC) Is Up 8.62% in One Week: What You Should Know - Yahoo Finance Australia

Feb 11, 2025

Phibro Animal Health (NASDAQ:PAHC) Reaches New 1-Year High on Analyst Upgrade - MarketBeat

Feb 11, 2025

Barclays Issues Positive Forecast for Phibro Animal Health (NASDAQ:PAHC) Stock Price - Defense World

Feb 11, 2025

Phibro Animal Health (NASDAQ:PAHC) Stock Price Up 6.8% on Analyst Upgrade - Defense World

Feb 11, 2025

Feb 10, 2025

Barclays lifts Phibro Animal Health target to $22, keeps underweight rating - MSN

Feb 10, 2025

Phibro Animal Health (NASDAQ:PAHC) Shares Up 6.8% Following Analyst Upgrade - MarketBeat

Feb 10, 2025

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance

Feb 10, 2025

Phibro (PAHC) Reliance on International Sales: What Investors Need to Know - Yahoo Finance

Feb 10, 2025

Phibro Animal Health (NASDAQ:PAHC) Price Target Raised to $22.00 - MarketBeat

Feb 10, 2025

Feb 09, 2025

Phibro Animal Health (NASDAQ:PAHC) Stock Rating Lowered by StockNews.com - MarketBeat

Feb 09, 2025

Phibro Animal Health Co. to Issue Quarterly Dividend of $0.12 (NASDAQ:PAHC) - MarketBeat

Feb 09, 2025

Feb 08, 2025

Phibro Animal Health (NASDAQ:PAHC) Shares Gap Up After Strong Earnings - MarketBeat

Feb 08, 2025

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12 - Yahoo Finance

Feb 08, 2025

Phibro Animal Health (NASDAQ:PAHC) Releases FY 2025 Earnings Guidance - MarketBeat

Feb 08, 2025

Feb 07, 2025

Phibro Animal Health (NASDAQ:PAHC) Updates FY 2025 Earnings Guidance - Armenian Reporter

Feb 07, 2025

Phibro Animal Health (NASDAQ:PAHC) Announces Earnings Results - Armenian Reporter

Feb 07, 2025

Phibro Animal Health Corporation (NASDAQ:PAHC) Q2 2025 Earnings Call Transcript - Insider Monkey

Feb 07, 2025

Morgan Stanley Lifts Price Target on Phibro Animal Health to $27 From $25, Keeps Equalweight Rating - Marketscreener.com

Feb 07, 2025

PAHC Stock Falls Despite Q2 Earnings & Revenue Beat, Margins Increase - Yahoo Finance

Feb 07, 2025

Phibro Animal Health Corporation Reports Strong Second Quarter Results and Updates Financial Guidance - Armenian Reporter

Feb 07, 2025